A study examined the cannabis compound tetrahydrocannabivarin (THCV) and found that it can potentially increase motivation and energy. The clinical study indicated that THCV produces these effects without the fatigue and increased appetite associated with Delta 9 tetrahydrocannabinol (THC-9). THCV is known as “diet weed” because it does not have appetite-inducing effects like other cannabinoids. This recent study indicates that this cannabinoid could have many therapeutic uses.
The cannabis genetics company Phylos collaborated with the cannabis research firm People Science to conduct this double-blind, placebo-control study. The researchers discovered that a THCV product can improve energy, activity, motivation, and well-being compared to a placebo treatment.
The researchers gave 78 participants either placebo gummies, delta-9 THC-only gummies, or gummies infused with THCV. The THCV gummies infused with distillate contained a 2:1 ratio of THCV: THC. Participants completed daily surveys and indicated their dosage. They were required to report any adverse reactions to the product.
The research team noted that 20 percent of participants who received the THCV gummies reported feeling more “energized” compared to those participants who ingested the placebo gummies. Forty percent described increased enjoyment of daily activities after taking THCV.
50% of participants who took the Delta 9 THC-infused gummy experienced increased hunger, but the researchers did not observe appetite stimulation as statistically significant in the THCV group. The Delta 9 THC-only group was three times as likely to report fatigue compared to participants who took the THCV gummies.
As more cannabinoid products enter the medical cannabis market and advanced formulations are developed, this study sheds significant light on THCV’s therapeutic properties.
Sources: Marijuana Moment, Phylos Bioscience
